-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Harvard Bioscience Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2024.
- Harvard Bioscience Inc Income Tax Expense (Benefit) for the quarter ending December 31, 2024 was $572K, a 20% decline year-over-year.
- Harvard Bioscience Inc Income Tax Expense (Benefit) for the twelve months ending December 31, 2024 was $740K, a 13.9% decline year-over-year.
- Harvard Bioscience Inc annual Income Tax Expense (Benefit) for 2024 was $740K, a 13.9% decline from 2023.
- Harvard Bioscience Inc annual Income Tax Expense (Benefit) for 2023 was $859K, a 155% increase from 2022.
- Harvard Bioscience Inc annual Income Tax Expense (Benefit) for 2022 was $337K, a 128% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)